Literature DB >> 14646593

Genomic organization and expression of parkin in Drosophila melanogaster.

Young-Joo Bae1, Kwang-Sook Park, Soon-Ja Kang.   

Abstract

We report here the isolation, characterization on genomic structure and expression of the D. melanogaster homolog of human parkin. The 2,122 bp parkin gene sequence contains six exons that form a 1,449 bp transcript encoding a protein of 482 amino acids. 151 bp of 5' and 112 bp of 3' untranslated regions were identified by a combination of 5'-RACE/primer extension and 3'-RACE, respectively. The 5' UTR contains three transcription initiation sites. Neither a classical TATA nor a CAAT box was found in the putative promoter sequence. However, binding sites for AhR-Arnt, AP4, NF1 and GATA transcription factors were identified. Transient transfection analysis of the 5' UTR confirmed its promoter activity in HEK 293 cells and SH-SY5Y neuronal cells using a dual luciferase reporting system. The amino acid sequence of D. melanogaster Parkin exhibits 42%, 43% and 43% identity to that of human, mouse and rat, respectively, representing a 54 kDa protein band via western blot analysis. It shows a high degree of conservation in the Ubiquitin-like domain at the N-terminus (34%), the In-Between RING finger domains (IBR, 65-69%), and the RING finger domains at the C-terminus (56-57%). The expression pattern of D. melanogaster parkin varies during the developmental stages, with the highest expression in the adult stage as measured by competitive RT-PCR. From immunostainings of the embryo, D. melanogaster parkin was expressed slightly higher in the central nervous system (brain and nerve cord) during the late embryonic stage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646593     DOI: 10.1038/emm.2003.52

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  6 in total

1.  Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on α-synuclein protein levels.

Authors:  Emmanuel González-Barbosa; Rosario García-Aguilar; Libia Vega; María Asunción Cabañas-Cortés; Frank J Gonzalez; José Segovia; Sara L Morales-Lázaro; Bulmaro Cisneros; Guillermo Elizondo
Journal:  Biochem Pharmacol       Date:  2019-08-09       Impact factor: 5.858

Review 2.  Modelling Parkinson's disease in Drosophila.

Authors:  José A Botella; Florian Bayersdorfer; Florian Gmeiner; Stephan Schneuwly
Journal:  Neuromolecular Med       Date:  2009-10-24       Impact factor: 3.843

3.  Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.

Authors:  Annika F M Haywood; Brian E Staveley
Journal:  BMC Neurosci       Date:  2004-04-16       Impact factor: 3.288

4.  Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene.

Authors:  Valentina La Cognata; Rosario Iemmolo; Velia D'Agata; Soraya Scuderi; Filippo Drago; Mario Zappia; Sebastiano Cavallaro
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

5.  Identification and molecular characterization of Parkin in Clonorchis sinensis.

Authors:  Xuelian Bai; Tae Im Kim; Ji-Yun Lee; Fuhong Dai; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2015-02-27       Impact factor: 1.341

6.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.